Kazia Therapeutics KZIA
NASDAQ KZIA
$9.27 -0.20 (-2.11%)
At close: Oct 2, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Change in Account Payables (2021 - 2023)

Updated

Kazia Therapeutics' Change in Account Payables was -$3.17 million in the year ended Jun 30, 2025.

Analysis

Kazia Therapeutics (KZIA) Change in Account Payables (2021 - 2023) Analysis & Trends

From the year ended Dec 31, 2009 onward, Kazia Therapeutics has reported Change in Account Payables for 17 years.

  • The figure for the year ended Jun 30, 2025 marks the lowest annual Change in Account Payables since the year ended Dec 31, 2013.
  • Per Business Quant data, Change in Account Payables in earlier years was $7.02 million in the year ended Dec 31, 2024 (+550.7%), $1.08 million in the year ended Dec 31, 2023, -$366,980 in the year ended Dec 31, 2022 and $759,121 in the year ended Dec 31, 2021 (-36.2%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 18.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Kazia Therapeutics 68.33 Mn 68.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 1.08 Mn
Dec 31, 2022 -401,671.59
Dec 31, 2021 1.17 Mn
API Access

Kazia Therapeutics Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=KZIA&period=max&api_key=YOUR_API_KEY